SIGA Announces BARDA Exercise of Contract Options Valued at $101.3 Million for the Procurement of Oral TPOXX®

NEXT STORY
BeiGene Announces Clinical Data to Be Presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting
PREV STORY
Apellis Pharmaceuticals Reports First Quarter 2020 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Provista Diagnostics Appoints Judith K. Wolf, M.D., as Chief Medical Officer

NEW YORK, July 28, 2016 (GLOBE NEWSWIRE) -- Provista Diagnostics Inc., a company developing ...

author_avatar
NASDAQ Market News

Eurobio Scientific acquires Dendritics, a company specializing in antibody development and manufacture

Eurobio Scientific acquires Dendritics,  a company specializing in antibody development and manufacture This strategic ...

author_avatar
NASDAQ Market News

CB-1158 (INCB01158) Phase I Solid Tumor Data Presented at the American Society of Clinical Oncology Annual Meeting

SOUTH SAN FRANCISCO, Calif., June 05, 2017 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), ...

author_avatar
NASDAQ Market News